Steps | Projects | Screening randomization | Follow-up | |||||
---|---|---|---|---|---|---|---|---|
No. of visit | 0 | 1 | 2 | 3 | 4 | 5 | 6 | |
Weeks | − 12 to − 4 | 0 | 4 | 8 | 12 | 24 | 48 | |
1 | Informed consent | × | ||||||
2 | Inclusion/exclusion criteria | × | ||||||
3 Clinical data | Basic data | × | ||||||
Randomization | × | |||||||
Concomitant medication | × | |||||||
Concomitant illness | × | |||||||
4 Examination | TSH | × | × | × | × | × | × | |
Vascular ultrasound | × | × | × | |||||
BMD | × | × | ||||||
Blood lipids (TC, LDL-C) | × | × | ||||||
5 | Adverse events | × | × | × | × | × | × | × |
6 | Deviation from the protocol | × | × | × | × | × | × | × |